Buys
Open market- Shares
- Avg price
- Total value
Adam Lezack - Director at Beta Bionics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- BBNX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Adam Lezack in Beta Bionics, Inc.
Sells
Open market- Shares
- -4,810
- Avg price
- $20.89
- Total value
- -$100,460
Net
Past year- Shares
- -4,810
- Share %
- -100%
- Total value
- -$100,460
Reported holdings for Adam Lezack in Beta Bionics, Inc.
Form 4 holding
Director
Beta Bionics, Inc.
- Security class
- Comon Stock
- Shares / value
- 27,399
- Estimated value
- $307,142
- Report date
- 22 May 2026
- Price
- $11.21
- Ownership
- Direct
Form 4 holding
Director
Beta Bionics, Inc.
- Security class
- Common Stock
- Shares / value
- 28,397
- Estimated value
- $284,537
- Report date
- 21 May 2026
- Price
- $10.02
- Ownership
- Direct
Form 4 holding
Director
Beta Bionics, Inc
- Security class
- Director Stock Option (right to buy)
- Shares / value
- 9,137
- Estimated value
- Report date
- 31 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Adam Lezack in Beta Bionics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.